(MedPage Today) — The FDA expanded the approval of a sublingual immunotherapy (SLIT; Odactra) for treating house dust mite allergies in young children, drugmaker ALK announced.
Taken as a once-daily tablet, the SLIT product is now indicated for…
Source link : https://www.medpagetoday.com/allergyimmunology/allergy/114441
Author :
Publish date : 2025-02-28 21:25:29
Copyright for syndicated content belongs to the linked Source.
